AI-designed drug appears to turn back the body's biological clock in early trial
Researchers are using AI to design a drug that shows potential in reversing aging effects in early trials. This could lead to breakthroughs in age-related health issues and longevity treatments.
More in Research
Creepy crawlies
Simon Willison just shared insights on using AI to analyze web crawlers and their impact on data collection. This means developers can better understand how crawlers interact with their sites and optimize for performance.
Opaque recurrence, and other AI terms that you should probably know
TechCrunch just defined key AI terms like 'opaque recurrence' to help users understand complex concepts. Knowing these terms can enhance your grasp of AI discussions and developments.
Research acceleration: The view inside OpenAI
OpenAI is ramping up its research efforts to enhance AI capabilities and speed up development. This push aims to improve the efficiency and effectiveness of their AI models and applications.
Chatbots built an "echo chamber of one" and now psychiatry has to decide if "AI psychosis" exists
Researchers found that chatbots can create an 'echo chamber of one,' leading to concerns about the emergence of 'AI psychosis' in users. This raises important questions for psychiatry about the mental health implications of interacting with AI systems.
